CBD may improve joint pain in canines, an animal model of arthritis deemed appropriate for assessing human arthritis pain, according to a new study. The study authors said follow-up investigations in humans are now warranted.
Several high-profile lawsuits challenging the legal status of CBD products have been stayed (effectively put on ice until the FDA outlines a regulatory path forward for CBD in foods & supplements) or voluntarily dismissed in recent weeks.
Data collected over two years of post-market surveillance offers strong support for the safety and tolerability of PlusCBD products from CV Sciences, with fewer than 0.03% of products producing any kind of adverse event.
The boom in hemp cultivation after the passage of the 2018 Farm Bill has created a supply bulge that the industry is still working through, observers say.
New claims creeping into the hemp/CBD space are indicative of the some of the unsolved regulatory issues that continue to distort the market. These include claims of ‘zero THC’ and ‘no CBD isolate.’
The ongoing CBD regulatory logjam has stunted the development of responsible, informative health claims for these products. I’ve speculated in these pages before that this will lead consumers to make it up as they go along. Two new studies seem to confirm...
Speaking via video, Michael McGuffin, president of the American Herbal Products Association (AHPA), discussed a range of issues, from new supplement users sticking with the products, voicing support for recent FDA/FTC actions against egregious drug claims,...
As cannabis legalization spreads across the country, professional sports leagues are updating their policies, while some players update their portfolios.
The regulatory issues that continue to cloud the CBD market have made room for alternative modes to affect the endocannabinoid system. Bolstered by recent bioavailability research, Gencor Pacifc thinks its Levagen PEA ingredient could be a winner.
URI has unveiled a new online Cannabis Studies program aimed at multiple positions in cannabis industry, from sales to lab technicians, and QA/QC to product development and manufacturing.
Nature’s Sunshine reversed years of sales declines in North America as demand for immune health products surged. This more than compensated for coronavirus-related sales declines in Asian markets.
NutraIngredients-USA's free webinar on May 14 will explore the science of hemp-derived cannabinoids (including CBD) and terpenes - there's still time to register.
The state of Texas has proposed rules for consumable hemp products that specify processing, testing, labeling and registration requirements. While the rules are characterized as reasonable and well thought out, they represent another patch in a state-by-state...
Every week, new studies are emerging that highlight the important roles that nutrients like vitamin D and zinc play for our immune systems, but the dietary supplements industry cannot talk about much of it. Eventually, this needs to be rectified, said...
While dietary supplement sales have surged in recent months, the extent of the economic damage caused by the novel coronavirus and COVID-19 could lead to some very tough quarters as families and businesses start to run out of money.
Mile High Labs has submitted a European novel foods dossier for its CBD isolate. According to Christian Hendriksen, vice president of international expansion, compliance with novel food regulations will help move CBD into the FMCG mainstream.
The State of Virginia has passed a law defining hemp extracts as an approved food. The law also allows a more liberal amount of THC in these products during the growth phase than does the federal description of industrial hemp.
The sad news came this week of the death of a young girl who started a movement, one which has exposed again the built-in strains of how the dietary supplement market is regulated in the United States.
Neptune Health and Wellness has received approval to transition one of its facilities for the production of hand sanitizer, the company announced today.
The US Food and Drug Administration has issued another warning letter on COVID-19 claims. This one was issued to a Nevada company marketing CBD products.
Consumers seem to be turning to hemp and cannabis products during the current crisis, which has buoyed the near term outlook for Curaleaf, one of the largest companies in the sector, which posted strong revenue growth in its recent annual report.
A recent paper detailing potential supplement-drug interactions gives a good overview of the issue without overemphasizing the potential safety concerns, an industry expert says.
The increasing popularity of cannabidiol (CBD) only underscores the need for accurate and informative labeling of hemp and hemp-derived CBD products, according to researchers.
CBD firm Charlotte’s Web reported $94.6 million in revenue in its annual report and announced an acquisition that expands its distribution into topical products.
The Natural Products Association (NPA) recently held a webinar on political and legislative insights. At the forefront — the expansion of health savings accounts, new dietary new dietary ingredient enforcement, DSHEA, accurate labels, and Cannabidiol...
The side effects of cannabidiol (CBD) products are ‘most probably’ due to native THC contamination rather than by direct action of CBD or its chemical transformation, according to a German-led study.
CBD has become one of the most mentioned health trends on social media, and according to research by Babylon Health, it also has the most research breadth behind it compared to other popular wellness fads such as 'clean beauty' and 'holistic...
The German Food and Agriculture Ministry (BMEL) has refuted an EU hemp group missive that the Ministry had changed its position regarding the novel food requirement for some cannabidiol (CBD) extracts in the EU.
By Hank Schultz, Elaine Watson and Elizabeth Crawford
A report on CBD delivered by FDA Commissioner Dr Stephen Hahn, MD, was seen by food and dietary supplement industry stakeholders as offering little hope of a timely regulatory solution for the ingredient.
NutraIngredients-USA will investigate the latest news at the upcoming Expo West trade show while at the same time trying not to get distracted by the weight of current events.
FDA Commissioner Dr Stephen Hahn, MD, in a speech on Wednesday, said that despite its continued concern about insufficient safety data, the FDA has no plans to try to shut down the CBD markets. Hahn said that would amount to a “fool’s game.”
The Food Safety Authority of Ireland (FSAI) has updated its recall of CBD-related foods and food supplements that have flagged up safety concerns due to the presence of delta‐9‐tetrahydrocannabinol or THC.
Retailers in the CBD space have expressed frustration at a recent survey, which finds products analysed breach food law with some posing as potential safety risks for consumers.
Cannabidiol (CBD) industry groups have welcomed new regulatory and precautionary advice by UK authorities highlighting its “clear trajectory towards developing a safe and legally compliant CBD industry.”
In a motion to dismiss a lawsuit* filed in California accusing it of selling ‘illegal’ CBD-infused products, PlusCBD Oil maker CV Sciences deploys multiple arguments: no one was harmed; plaintiffs lack standing to seek label changes; the case is pre-empted...
The Natural Products Association credits a grass roots pressure campaign with forestalling the advance of two troublesome Illinois State measures. One affects weight management supplements and the other CBD businesses.
Online cannabis giant Global Cannabinoids recently announced the release of their new 2020 catalog of hemp-derived cannabinoid oils, isolates, and finished products for both white and private labels.
Emboldened by a recent court ruling in Florida that stayed a CBD-related class action on primary jurisdiction grounds (ie. putting the case on ice until the FDA weighs in), multiple brands hit with similar lawsuits are now pushing for stays and referencing...
Dietary supplement industry stakeholders are divided over whether proposed legislation to alter the regulatory definitions of dietary ingredients to specifically include CBD is the best way to break the logjam on the substance.
An analysis of recent warning letters underscores the notion that FDA is focused its enforcement efforts on CBD, and is not targeting hemp extracts per se.
The year is new and a lot of people are getting out their crystal balls. NutraIngredients-USA is no exception, and here are our top big issues that will impact the dietary supplements industry in this new decade.
Building on a regulatory foundation already laid for hemp ingredients, Rep. Collin Peterson (D-MN) has proposed a bill that would include CBD under the definition of dietary supplements found in DSHEA.
Holista CollTech has filed for a global patent for its water-soluble delivery system, which it claims makes fat-soluble molecules such as cannabidiol (CBD) more readily absorbed by the body.
